Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 6/20 | 0.37 |
| ▸ | PTK2 | Q05397 | 8/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.34 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3450657 | 0.92 | SYK (0.39) | SYKPTK2MAPTNPSR1CSNK1A1 | |
| SCHEMBL3448606 | 0.89 | SYK (0.37) | SYKPTK2MAPTNPSR1CSNK1A1 | |
| SCHEMBL3452624 | 0.89 | SYK (0.48) | SYK | |
| SCHEMBL3374672 | 0.87 | SYK (0.48) | SYKMAPTNPSR1 | |
| SCHEMBL3374661 | 0.87 | SYK (0.45) | SYKPTK2MAPTNPSR1CSNK1A1 | |
| SCHEMBL3448235 | 0.87 | SYK (0.49) | SYKPTK2MAPTNPSR1CSNK1A1 | |
| SCHEMBL3450416 | 0.83 | GPR52 (0.42) | SYKPTK2ABL1 | |
| SCHEMBL3449562 | 0.83 | MAPT (0.36) | SYKPTK2MAPTNPSR1CSNK1A1 | |
| SCHEMBL3447449 | 0.82 | SYK (0.37) | SYKMAPTNPSR1CSNK1A1 | |
| SCHEMBL3451524 | 0.82 | SYK (0.40) | SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11600791-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3936512-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3424935-B1 | IMIDAZOPYRAZINYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-18 | — | — | US | disclosed |
| US-10873038-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-12-22 | — | — | US | disclosed |
| EP-3313397-B1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | MERCK SHARP & DOHME (US) | 2020-11-25 | — | — | EP | disclosed |
| US-20190109287-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-11 | — | — | US | disclosed |
| EP-3424935-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-2683728-B1 | IRIDIUM COMPLEXES WITH 3-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE, 3-PHENYL-3H-IMIDAZO[4,5-b]PYRAZINE AND 1-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE CARBENE LIGANDS USED AS PHOSPHORESCENT EMITTERS IN ORGANIC LIGHT EMITTING DEVICES | UNIVERSAL DISPLAY CORP (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9972793-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-15 | — | — | US | disclosed |
| US-8883322-B2 | Pyridyl carbene phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2014-11-11 | — | — | US | disclosed |
| EP-2683728-A2 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2014-01-15 | — | — | EP | disclosed |
| WO-2012121936-A2 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| US-20100137313-A1 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | ASTRAZENECA AB | 2010-06-03 | — | — | US | disclosed |
| US-20100137313-A1 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | ASTRAZENECA AB | 2010-06-03 | — | — | US | disclosed |
| US-20100137313-A1 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | ASTRAZENECA AB | 2010-06-03 | — | — | US | disclosed |
| WO-2010038081-A2 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010038081-A2 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2010-04-08 | — | — | WO | disclosed |
| US-20100029643-A1 | HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY | ASTRAZENECA AB (SE) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137313-A1 | HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF | SDHA, SDHB, UROD | SYK 804/4885PTK2 3971/4885MAPT 3947/4885 |
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NUDC, NCL, NDC1 | SYK 1309/4885PTK2 2611/4885MAPT 608/4885 |
| US-10873038-B2 | Organic electroluminescent materials and devices | NUDC, NCL, NDC1 | SYK 1309/4885PTK2 2611/4885MAPT 608/4885 |
| US-20100029643-A1 | HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY | EDF1, ERLIN1, ECE1 | SYK 1784/4885PTK2 3443/4885MAPT 4806/4885 |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | PAICS, PIR, NUDC | SYK 1334/4885PTK2 2447/4885MAPT 672/4885 |
| US-20190109287-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NUDC, NCL, NDC1 | SYK 1309/4885PTK2 2611/4885MAPT 608/4885 |
| US-11600791-B2 | Organic electroluminescent materials and devices | NUDC, NCL, NDC1 | SYK 1309/4885PTK2 2611/4885MAPT 608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.